North Star Investment Management’s Altimmune ALT Stock Holding History

North Star Investment Management’s Portfolio ALT Stock Details ALT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$52.4K	Buy	17,000 +9,000	+113%	+$38.2K	﹤0.01%	725
2025 Q4	$28.9K	Hold	8,000	–	–	﹤0.01%	788
2025 Q3	$30.2K	Sell	8,000 -9,000	-53%	-$34.8K	﹤0.01%	756
2025 Q2	$65.8K	Sell	17,000 -13,000	-43%	-$70.4K	﹤0.01%	587
2025 Q1	$150K	Hold	30,000	–	–	0.01%	452
2024 Q4	$216K	Buy	30,000 +15,900	+113%	+$121K	0.02%	404
2024 Q3	$86.6K	Buy	14,100 +1,000	+8%	+$6.78K	0.01%	525
2024 Q2	$87.1K	Buy	13,100 +10,100	+337%	+$74.5K	0.01%	520
2024 Q1	$30.5K	Buy	+3,000	New	+$30.5K	﹤0.01%	683
2017 Q3	–	Sell	-3	Closed	–	–	1081
2017 Q2	$0	Hold	3	–	–	﹤0.01%	1074
2017 Q1	$1K	Hold	3	–	–	﹤0.01%	1001
2016 Q4	$3K	Buy	+3	New	+$2.69K	﹤0.01%	871

Other funds holding ALT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

North Star Investment Management's ALT Position: Q1 2026 in Review

North Star Investment Management increased its Altimmune (ALT) stake by 113% in Q1 2026, buying an estimated $38.2K and bringing the position to 17,000 shares worth $52.4K. The position accounts for ﹤0.01% of the portfolio, ranked #725.

North Star Investment Management first reported a position in ALT in Q4 2016 and has held it in 12 quarters since. The position peaked at $216K in Q4 2024. 173 funds tracked by Wall St. Rank hold ALT as of Q1 2026.

North Star Investment Management held 17,000 shares of Altimmune worth $52.4K as of Q1 2026.
North Star Investment Management bought 9,000 Altimmune shares in Q1 2026, an estimated $38.2K.
Altimmune made up ﹤0.01% of North Star Investment Management's portfolio in Q1 2026, its #725 holding.
North Star Investment Management first reported a position in Altimmune in Q4 2016 and has held it in 12 quarters since.
North Star Investment Management's Altimmune position peaked at $216K in Q4 2024.
173 funds tracked by Wall St. Rank held Altimmune as of Q1 2026.

Based on North Star Investment Management's 13F filing for Q1 2026, filed 23 Apr 2026.